New research illustrates role of CETP in atherosclerosis

Supports concept of avant immunotherapeutics' atherosclerosis vaccine

NEEDHAM, MA (November 29, 1999): New research demonstrates that the cholesteryl ester transfer protein (CETP) can promote atherosclerosis, thus supporting the novel vaccine approach to preventing or treating that disease now under development by AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN). A study published in the December issue of Nature Medicine by researchers from Boston University School of Medicine and AVANT describes the creation of a transgenic rat model that carries the human gene for CETP in a rat strain that develops high blood pressure. As they aged, such rats developed severely high cholesterol and triglyceride levels, atherosclerotic lesions, myocardial infarctions (heart attacks), and had decreased survival, thus closely mimicking human atherosclerosis and coronary heart disease.

"This research strongly suggests that elevated CETP may contribute to the development of atherosclerosis in humans. It also substantiates a mechanism for the known epidemiological link between increased risk of coronary heart disease and increasing severity of hypertension," said Victoria L. M. Herrera of Boston University School of Medicine, lead author of the publication. "We believe this transgenic rat line will prove a useful predictive model for research in cardiovascular disease."

The normal role of CETP in the body is to shuttle cholesterol from high density lipoprotein (HDL, or "good" cholesterol) to low density lipoprotein (LDL, or "bad" cholesterol), thus controlling in part the relative levels of those two substances. High levels of LDL and low levels of HDL are known to contribute to atherosclerosis. AVANT's investigational vaccine is designed to raise serum HDL cholesterol levels by inducing antibodies against a critical portion of the CETP molecule, thus blocking its cholesterol shuttling activity and inducing a plasma lipoprotein profile consistent with a low

Contact: Joan Kureczka
Kureczka/Martin Associates

Page: 1 2 3

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
3. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
4. Belgian researchers explore revolutionary approach to angiogenesis
5. Award winning researchers reveal potential new role for Glivec
6. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
7. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
8. Gene chips research in cotton could lead to superior variety
9. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
10. New hydrothermal vents discovered as South Pacific Odyssey research begins
11. University of Alberta researcher looks for clues to mysterious disease

Post Your Comments:

(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first ... insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and ... be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual ...
(Date:7/2/2020)... (PRWEB) , ... July 02, ... ... Biology Systems, B.V. (MBS) has announced a publication detailing the use of ... reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled ...
(Date:6/28/2020)... , ... June 25, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that it has entered ... innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has ... From the Paris Agreement to stock market dips, ways to reduce CO2 is something ... to their portfolio. Most of the biofuels being produced today are created from recycled ...
(Date:5/30/2020)... NEW YORK (PRWEB) , ... May 29, 2020 ... ... launch of Chief Medical Officer 360°, the first newsletter solely dedicated to the ... will capture a wide range of perspectives on the responsibilities, problem-solving, best practices ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... will cause long-term harm , Contrary to conventional wisdom that says the coronavirus ... finds many companies will emerge from the pandemic commercially weaker, dealing with delays ...
(Date:5/15/2020)... Md. (PRWEB) , ... May ... ... leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and ... to enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). ...
Breaking Biology Technology:
Cached News: